New Year Bumper Sale @ Rs. 1 X
Anna is an allopathic medicine The correct dosage of Anna depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Anna is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Anna safe for pregnant women?
Anna should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Anna safe during breastfeeding?
Breastfeeding women can safely use Anna.
What is the effect of Anna on the Kidneys?
Anna rarely harms the kidneys.
What is the effect of Anna on the Liver?
Using Anna does not have any harmful effects on the liver.
What is the effect of Anna on the Heart?
Anna is not harmful for the heart.
Anna should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Anna unless your doctor advises you to do so -
Is this Anna habit forming or addictive?
No, there is no any evidence that Anna is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Anna you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Anna is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Anna is not used to treat mental disorders.
Interaction between Food and Anna
Taking Anna with food is safe.
Interaction between Alcohol and Anna
No research has been done on this till date. Therefore, it is not known what the effect of taking Anna with alcohol will be.
Yes, Anna causes stomach upset. It is a common side effect of this drug but the exact cause behind it is not known. Please inform your doctor if you are experiencing stomach upset after taking this medicine.
Yes, Anna can be taken with phenylephrine. No harmful drug interactions have been reported between them. However, if you feel any discomfort or unpleasant effects after taking this drug to inform your doctor immediately.
No, Anna Should not be stopped or discontinued without doctors advice. You are recommended to always consult a doctor before discontinuing this medicine. Suddenly stopping Anna can cause withdrawal symptoms.
Anna works by suppressing body's normal immune response to inflammation which is responsible for symptoms such as swelling, redness and itching. This results in decreased inflammation and provides relief from the symptoms associated with it.
Take Anna as advised by your doctor. Do not discontinue the drug suddenly or take it longer than prescribed by your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qvar® Redihaler™ (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-356
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; QVAR® (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Gentamicin
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 747-748